You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VERA Sale Disclosure
Fordyce Marshall · SEC Form 4 · Filed Jul 9, 2026
Sale
Calculated transaction value
$450.01K
Fordyce Marshall President And CEO
VERA
Vera Therapeutics
VERA
Transaction date
Jul 7, 2026
Public filing date
Jul 9, 2026
Filing lag
Filed 2 days later
VERA daily price context
Close on/before transaction
$42.96
Jul 7, 2026
First close after public filing
$42
Jul 10, 2026
30-day return after filing
-24.81%
Through Aug 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 10,500 shares @ $42.86
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001859453-26-000010
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.96M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vera Therapeutics, Inc. VERA | Sale | Jul 7, 2026 | $40.78K |
| Vera Therapeutics, Inc. VERA | Sale | Jul 7, 2026 | $1.37M |
| Vera Therapeutics, Inc. VERA Current | Sale | Jul 7, 2026 | $450.01K |
| Vera Therapeutics, Inc. VERA | Sale | Jul 7, 2026 | $95.91K |